5-[[6-chloro-5-(2-fluoro-4-methoxyphenyl)-1H-benzimidazol-2-yl]oxy]-2-methylcyclohexa-1,5-diene-1-carboxylic acid
C22H18ClFN2O4 — CID 143996146
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[[6-chloro-5-(2-fluoro-4-methoxyphenyl)-1H-benzimidazol-2-yl]oxy]-2-methylcyclohexa-1,5-diene-1-carboxylic acid
5-[[6-chloro-5-(2-fluoro-4-methoxyphenyl)-1H-benzimidazol-2-yl]oxy]-2-methylcyclohexa-1,5-diene-1-carboxylic acid (PubChem CID 143996146) has the molecular formula C22H18ClFN2O4 and a molecular weight of 428.85 g/mol. Its IUPAC name is 5-[[6-chloro-5-(2-fluoro-4-methoxyphenyl)-1H-benzimidazol-2-yl]oxy]-2-methylcyclohexa-1,5-diene-1-carboxylic acid.
Molecular Properties
| Compound Name | 5-[[6-chloro-5-(2-fluoro-4-methoxyphenyl)-1H-benzimidazol-2-yl]oxy]-2-methylcyclohexa-1,5-diene-1-carboxylic acid |
|---|---|
| PubChem CID | 143996146 |
| Molecular Formula | C22H18ClFN2O4 |
| Molecular Weight | 428.85 g/mol |
| Exact Mass | 428.09 |
| IUPAC Name | 5-[[6-chloro-5-(2-fluoro-4-methoxyphenyl)-1H-benzimidazol-2-yl]oxy]-2-methylcyclohexa-1,5-diene-1-carboxylic acid |
| SMILES | COc1ccc(-c2cc3nc(OC4=CC(C(=O)O)=C(C)CC4)[nH]c3cc2Cl)c(F)c1 |
| InChI | InChI=1S/C22H18ClFN2O4/c1-11-3-4-13(7-15(11)21(27)28)30-22-25-19-9-16(17(23)10-20(19)26-22)14-6-5-12(29-2)8-18(14)24/h5-10H,3-4H2,1-2H3,(H,25,26)(H,27,28) |
| InChIKey | XGCTWRQMCDFSRE-UHFFFAOYSA-N |
| XLogP | 5.49 |
| TPSA | 84.44 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 428.85 |
| LogP ≤ 5 | 5.49 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143996146 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.